Inventor · disambiguated record
Joseph Hulihan
Also filed as: HULIHAN JOSEPH
9 granted patents·6 pending applications·15 citations·filing 2021–2024
84Inventor score
Top patents by PatentIndex Score
15 records- 0194US12115169B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2024·Granted Oct 15, 2024·3 cites·24 claims
- 0294US11980625B2Ganaxolone for use in treating tuberous sclerosis complexMARINUS PHARMACEUTICALS INC·Filed 2023·Granted May 14, 2024·4 cites·25 claims
- 0394US11701367B2Ganaxolone for use in treating tuberous sclerosis complexMARINUS PHARMACEUTICALS INC·Filed 2022·Granted Jul 18, 2023·4 cites·25 claims
- 0492US11110100B2Ganaxolone for use in treatment of status epilepticusMARINUS PHARMACEUTICALS INC·Filed 2021·Granted Sep 7, 2021·3 cites·21 claims
- 0587US12268696B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2024·Granted Apr 8, 2025·0 cites·22 claims
- 0687US12246026B2Ganaxolone for use in treatment of status epilepticusMARINUS PHARMACEUTICALS INC·Filed 2021·Granted Mar 11, 2025·1 cites·26 claims
- 0784US2025032512A1Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0883US12390477B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersIMMEDICA PHARMA US INC·Filed 2024·Granted Aug 19, 2025·0 cites·22 claims
- 0983US12383564B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersIMMEDICA PHARMA US INC·Filed 2024·Granted Aug 12, 2025·0 cites·22 claims
- 1080US2023405021A1Ganaxolone for use in treatment of status epilepticusMARINUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1178US11679117B2Ganaxolone for use in treatment of status epilepticusMARINUS PHARMACEUTICALS INC·Filed 2022·Granted Jun 20, 2023·0 cites·28 claims
- 1277US2024374614A1Ganaxolone for use in treating tuberous sclerosis complexMARINUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1362US2024245709A1Ganaxolone for use in treatment of established status epilepticusMARINUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1460US2023321117A1Use of ganaxolone in treating an epilepsy disorderMARINUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1559US2023364109A1Ganaxolone for use in treatment of super refractory status epilepticusMARINUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Hulihan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →